Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

About 61% of women who had COVID-19 experienced hair loss afterward.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

COVID-19 infection can significantly cause temporary hair loss.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

People with cleft lip and palate often have respiratory problems.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Long COVID causes lasting symptoms and needs ongoing care.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

The treatment might help COVID-19 related hair loss, but more research is needed.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.